N-Acetyl Epitalon Amidate

Preclinical only Anti-Aging & Longevity 3 sources

N-Acetyl Epitalon Amidate is a modified version of the synthetic tetrapeptide Epitalon (Epithalon), featuring an N-terminal acetyl group and a C-terminal primary amide. These modifications are designed to enhance the peptide's stability, bioavailability, and resistance to enzymatic degradation. Like the original Epitalon, it is researched for its potential to activate telomerase, lengthen telomeres, and support cellular longevity and repair.

01Dosing reference

Amount

100-500 mcg/day (often lower than standard Epitalon due to enhanced stability)

Frequency

Once daily

Cycle

10-20 days per cycle, repeated 1-2 times per year

Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

Enhanced Stability

The N-terminal acetylation and C-terminal amidation protect the peptide from rapid breakdown by exopeptidases in the body.

Telomerase Activation

The peptide interacts with cellular mechanisms to upregulate the expression of the telomerase enzyme (hTERT).

Telomere Elongation

Increased telomerase activity helps maintain or lengthen telomeres at the ends of chromosomes, potentially delaying cellular senescence and aging.

03Human evidence

Lack of direct human clinical trials

While the original Epitalon has been studied in humans (showing benefits in melatonin regulation and aging markers), N-Acetyl Epitalon Amidate specifically lacks published, peer-reviewed human clinical trials. It is currently restricted to preclinical and laboratory research.

04Preclinical evidence

Telomerase upregulation in human cell lines

In vitro studies on the base peptide Epitalon demonstrate its ability to induce telomerase activity and elongate telomeres in human somatic cells, suggesting the amidated version would have similar or enhanced effects due to better stability.

Protection against cellular aging

Research on Epitalon derivatives in animal models and cell cultures shows protection against oxidative stress and aging-related damage, such as modulating mitochondrial activity and reducing ROS levels.

05What is known vs. unknown

Reasonably established

It is a structurally modified version of Epitalon (Ala-Glu-Asp-Gly) designed for better stability and bioavailability.
The primary mechanism of interest is the upregulation of telomerase and subsequent elongation of telomeres.
It is derived from Epithalamin, a naturally occurring polypeptide complex found in the pineal gland.
Research suggests potential benefits in regulating circadian rhythms and melatonin production, similar to the base peptide.

Unknowns & limits

There is a lack of direct human clinical trials specifically testing the N-Acetyl Amidate version compared to standard Epitalon.
The exact difference in half-life and in vivo efficacy between standard Epitalon and the modified version remains fully unquantified in human subjects.
Long-term safety and potential risks of prolonged telomerase activation (such as theoretical cancer risks) require further investigation.

06Safety & regulatory context

Regulatory statusN-Acetyl Epitalon Amidate is strictly a research chemical and is not approved by the FDA or any other regulatory body for human consumption or medical use. Because it lacks human clinical trials, its safety profile is largely extrapolated from studies on standard Epitalon, which generally showed low toxicity in animal models. However, the theoretical risk of uncontrolled cell proliferation (cancer) associated with telomerase activators remains a concern in the scientific community. It should only be used in controlled laboratory settings.

07Compared with Epitalon (Standard)

N-Acetyl Epitalon Amidate vs. Epitalon (Standard)

Key difference

N-Acetyl Epitalon Amidate has added chemical groups (acetylation and amidation) that protect it from enzymatic degradation, theoretically increasing its half-life and bioavailability compared to standard Epitalon.

When researchers discuss each

Standard Epitalon is discussed when referencing historical Russian clinical trials and established literature. The N-Acetyl Amidate version is discussed in modern experimental contexts focusing on maximizing peptide stability and efficacy.

08Glossary

Telomerase

An enzyme that adds DNA sequence repeats to the ends of chromosomes (telomeres), helping to prevent them from shortening during cell division.

Telomere

The protective caps at the ends of chromosomes that naturally shorten as cells divide and age.

Acetylation

A chemical modification where an acetyl group is added to a molecule, often used in peptides to prevent breakdown by enzymes.

Amidation

The addition of an amide group to the end of a peptide chain, which increases its stability and mimics natural proteins.

09Knowledge check

Q1What is the primary purpose of adding the N-Acetyl and Amidate groups to the Epitalon peptide?

Q2Which enzyme is Epitalon primarily researched for activating?

Q3Which conclusion is best supported by the dossier about human evidence for N-Acetyl Epitalon Amidate?

Q4According to the dossier, what is the stated key chemical difference between N‑Acetyl Epitalon Amidate and standard Epitalon?

Q5Which statement best reflects the safety and regulatory context provided in the dossier?

10Sources

More in Anti-Aging & Longevity

See all

Epitalon

Anti-Aging & Longevity

Human clinical

Epitalon is a synthetic tetrapeptide designed to mimic the effects of epithalamin, a natural polypeptide produced in the pineal gland. Research suggests it can activate telomerase, elongate telomeres, regulate melatonin production, and potentially extend lifespan in animal models.

5-10 mg/day

SS-31 (Elamipretide)

Anti-Aging & Longevity

Human clinical

SS-31, also known as elamipretide, is a mitochondria-targeted peptide that binds to cardiolipin in the inner mitochondrial membrane. It helps restore mitochondrial function, reduce oxidative stress, and improve cellular energy production. Research has heavily focused on its potential for treating heart failure, mitochondrial myopathies, and age-related cellular decline.

2-4 mg/day

FOXO4-DRI

Anti-Aging & Longevity

Preclinical only

FOXO4-DRI is an engineered peptide designed to selectively induce apoptosis (programmed cell death) in senescent cells. Research in animal models suggests it can clear these 'zombie cells' by disrupting the interaction between the FOXO4 and p53 proteins, potentially reversing signs of aging and restoring tissue function.

1-3 mg/day (theoretical research dose)

Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.